API | neuroaid

neuroaid Report issue

Botanical Experimental

AACT MeSH

Active Ingredient History

NOW

NeuroAiD is a herbal supplement proposed to support functional recovery after strokes. There were two formulations of NeuroAiD: MLC601 (NeuroAiDTM) was first developed. Since 2018 MLC601 formulation is no longer on the market, and has been replaced by MLC901 (NeuroAiDTMII), a simplified formulation containing only 9 botanical ingredients. It can be administered orally or through a feeding tube. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecules: Missing data

More Chemistry

Pharmacology

Mechanism of Action:
Multi-specific: Missing data
Black Box: Missing data
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: Missing data

mlc 601 | mlc901 | mlc 901 | neuroaid

Organizations (9)

Research & Development (9)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (6)

Approved Indications (1)

Cognition

Experimental Indications - Clinical Trial Phases 1-4 (5)

Alzheimer Disease (Phase 2)

Cerebral Infarction (Phase 3)

Cognitive Dysfunction (Phase 2)

Spinal Cord Injuries (Phase 4)

Stroke (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 6
# of Trial Organizations: 9

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue